期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Prospects for PARG inhibitors in cancer therapy
1
作者 Yangchan Hu Yuxin Meng +5 位作者 Zirui Zhuang Yuancong Li junjun nan Ning Xu Zu Ye Ji Jing 《Journal of Molecular Cell Biology》 CSCD 2024年第11期1-14,共14页
Poly(ADP-ribose)glycosylhydrolase(PARG)is an enzyme involved in hydrolyzing the ribose–ribose bonds present in poly(ADP-ribose)(PAR),which are primarily found in the nucleus.Along with poly(ADP-ribose)polymerase,PARG... Poly(ADP-ribose)glycosylhydrolase(PARG)is an enzyme involved in hydrolyzing the ribose–ribose bonds present in poly(ADP-ribose)(PAR),which are primarily found in the nucleus.Along with poly(ADP-ribose)polymerase,PARG regulates the level of PAR in cells,playing a crucial role in DNA maintenance and repair processes.Recent studies have revealed elevated levels of PARG in various cancers,such as breast,liver,prostate,and esophageal cancers,indicating a link to unfavorable cancer outcomes.PARG is a significant molecular target for treating PAR-related cancers.This review provides a comprehensive overview of the physiological role of PARG and the development of its inhibitors,highlighting its potential as an innovative target for cancer treatment. 展开更多
关键词 PARG PARG inhibitor cancer therapy
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部